Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Mycoses|January 25, 2018
Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropeniaPranatharthi Chandrasekar, Bhawna Sirohi, Nita L Seibel, et al.Mycoses|October 10, 2015
Estimated burden of fungal infections in GermanyMarkus Ruhnke, Andreas H Groll, Peter Mayser, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2021
EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working GroupMatteo Bassetti, Elie Azoulay, Bart-Jan Kullberg, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2006
Economic evaluation of voriconazole versus conventional amphotericin B in the treatment of invasive aspergillosis in GermanyJeroen P Jansen, Winfried V Kern, Oliver A Cornely, et al.Mycoses|December 14, 2011
A real-time PCR for the detection and characterisation of Aspergillus speciesStephan Fricke, Christian Fricke, Christopher Oelkrug, et al.Medical Mycology|September 8, 2010
Doxorubicin induces drug efflux pumps in Candida albicansGrzegorz Kofla, Vincent Turner, Bettina Schulz, et al.Mycoses|January 18, 2012
Interlaboratory comparison of PCR-based identification of Candida and Aspergillus DNA in spiked blood samplesUtz Reichard, Dieter Buchheidt, Cornelia Lass-Flörl, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2002
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosisDavid W Denning, Patricia Ribaud, Noel Milpied, et al.Breast (Edinburgh, Scotland)|September 6, 2021
First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI studyVolkmar Müller, Markus Ruhnke, Oliver Hoffmann, et al.Onkologie|March 15, 2013
Management of cytotoxic extravasation - ASORS expert opinion for diagnosis, prevention and treatmentMaike de Wit, Petra Ortner, Hans-Peter Lipp, et al.Pageof 6